Edition:
United Kingdom

RTI Surgical Inc (RTIX.OQ)

RTIX.OQ on NASDAQ Stock Exchange Global Select Market

4.16USD
17 Dec 2018
Change (% chg)

$0.01 (+0.24%)
Prev Close
$4.15
Open
$4.16
Day's High
$4.16
Day's Low
$4.16
Volume
1,808
Avg. Vol
30,760
52-wk High
$5.05
52-wk Low
$3.81

Latest Key Developments (Source: Significant Developments)

RTI Surgical Q2 Loss Per Share $0.10
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - RTI Surgical Inc ::RTI SURGICAL ANNOUNCES SECOND QUARTER 2018 RESULTS.Q2 LOSS PER SHARE $0.10.Q2 REVENUE $70.7 MILLION VERSUS I/B/E/S VIEW $70.2 MILLION.Q2 ADJUSTED EARNINGS PER SHARE $0.03 EXCLUDING ITEMS.SEES FY 2018 REVENUE $280 MILLION TO $290 MILLION.Q2 EARNINGS PER SHARE VIEW $0.01 -- THOMSON REUTERS I/B/E/S.COMPANY IS REITERATING FINANCIAL GUIDANCE FOR 2018, ORIGINALLY ISSUED ON JANUARY 5, 2018.  Full Article

RTI Surgical Outlines 2018 Guidance And Long-Term Goals
Friday, 5 Jan 2018 

Jan 5 (Reuters) - RTI Surgical Inc ::RTI SURGICAL OUTLINES 2018 GUIDANCE AND LONG-TERM GOALS.RTI SURGICAL INC - EXPECTS FULL YEAR REVENUES IN RANGE OF $280 MILLION AND $290 MILLION.RTI SURGICAL INC - ‍EXPECTS FULL YEAR EBITDA TO BE IN RANGE OF $32 MILLION TO $38 MILLION​.RTI SURGICAL - CO TO EXPAND REVENUE TO MORE THAN $500 MILLION​ AS ‍LONG-TERM FINANCIAL GOAL, EXPECTED TO BE ACHIEVED WITHIN FIVE YEARS.RTI SURGICAL - CO TO ‍DOUBLE EBITDA MARGIN TO MORE THAN 20 PERCENT AS LONG TERM FINANCIAL GOAL, EXPECTED TO BE ACHIEVED WITHIN FIVE YEARS ​.  Full Article

RTI Surgical Announces Acquisition Of Zyga Technology
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - RTI Surgical Inc ::RTI SURGICAL ANNOUNCES ACQUISITION OF ZYGA TECHNOLOGY, INC..RTI SURGICAL INC - TERMS OF DEAL WERE NOT DISCLOSED..RTI SURGICAL - CO TO FUND DEAL WITH CASH AND BORROWING UNDER EXISTING CREDIT FACILITY.  Full Article

RTI Surgical receives warning letter from FDA
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - RTI Surgical Inc :On Nov 9, co received a warning letter from FDA resulting from an inspection of co's facility in Alachua, Florida in April.Warning letter relates to processes used in manufacture of map3 cellular allogeneic bone graft product ​.Warning letter also relates to FDA's views with respect to map3 allograft's regulatory classification​.Warning letter does not restrict production, marketing, or distribution of map3 allograft​.Intends to conduct clinical studies that further confirm safety and efficacy of map3(reg) allograft​.  Full Article

RTI Surgical Q3 earnings per share $0.23
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - RTI Surgical Inc ::RTI Surgical announces 2017 third quarter results.Q3 earnings per share $0.23.Q3 earnings per share view $0.01 -- Thomson Reuters I/B/E/S.Sees FY 2017 adjusted earnings per share $0.05 to $0.07.Sees FY 2017 earnings per share $0.21 to $0.23.Q3 adjusted earnings per share $0.01 excluding items.Sees FY 2017 revenue $274 million to $280 million.Q3 revenue $66.7 million versus I/B/E/S view $65.4 million.FY 2017 earnings per share view $0.06, revenue view $277.8 million -- Thomson Reuters I/B/E/S.  Full Article